Barst, Robyn J <br/><br/>
Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension.  [electronic resource] 

 -  Expert opinion on pharmacotherapy  Jan 2007 
 - 95-109 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7666 
<br/><br/><label>Standard No.: </label>10.1517/14656566.8.1.95  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Endothelin A Receptor Antagonists<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Isoxazoles--pharmacology<br/>Multicenter Studies as Topic<br/>Randomized Controlled Trials as Topic<br/>Receptor, Endothelin A--physiology<br/>Thiophenes--pharmacology